About
This combination medication contains Empagliflozin and Metformin, offering a powerful dual-action approach to effectively manage type 2 diabetes mellitus. Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, works by blocking the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine and a subsequent reduction in blood glucose levels. This mechanism is independent of insulin. Metformin, a biguanide, complements this action by primarily reducing glucose production by the liver and enhancing the body's sensitivity to insulin in muscle and fat tissues. This synergistic action helps to lower both fasting and postprandial blood glucose, providing robust glycemic control. Beyond its glucose-lowering effects, Empagliflozin has also demonstrated significant cardiovascular benefits, including a reduction in the risk of cardiovascular death and hospitalization for heart failure, as well as renal protective effects, making this combination a valuable option for comprehensive diabetes management.
Uses
- Management of type 2 diabetes mellitus.
- Improvement of glycemic control.
- When diet and exercise alone are insufficient.
- For patients inadequately controlled on monotherapy.
Directions For Use
Take orally with meals, usually once or twice daily, as directed by your physician. Swallow the tablet whole; do not crush or chew.
Benefits
- Effective blood sugar reduction.
- Potential for weight loss.
- Reduced risk of cardiovascular events.
- Renal protective effects.
- Improved insulin sensitivity.
- Convenient combination therapy.
Side Effects
- Hypoglycemia (especially with other agents)
- Genital yeast infections
- Urinary tract infections
- Nausea
- Diarrhea
- Abdominal pain
- Increased urination
- Headache
- Metallic taste
- Lactic acidosis (rare but serious)
- Ketoacidosis (rare)
- Vitamin B12 deficiency
Safety Measures
- Alcohol - Avoid excessive alcohol consumption as it can increase the risk of hypoglycemia and lactic acidosis, especially with Metformin.
- Pregnancy - Not recommended during pregnancy. Insulin is generally preferred for glycemic control in pregnant women. Consult your doctor.
- Breastfeeding - Not recommended during breastfeeding as components may pass into breast milk. Seek medical advice.
- Liver - Use with caution in patients with liver impairment due to increased risk of lactic acidosis (Metformin) and potential impact on drug metabolism.
- Kidney - Contraindicated in severe renal impairment (Metformin, Empagliflozin). Dose adjustment is necessary for moderate impairment.
- Lung - Severe respiratory insufficiency can increase the risk of lactic acidosis (Metformin). Use with caution in such cases.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!